Nuclear Medicine and Biology
Volume 33, Issue 6 , Pages 715-722, August 2006

A 99mTc-labeled gemcitabine bisphosphonate drug conjugate as a probe to assess the potential for targeted chemotherapy of metastatic bone cancer

  • Amal A. El-Mabhouh

      Affiliations

    • Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta T6G 2N8, Canada
    • ,
  • Christo A. Angelov

      Affiliations

    • Department of Chemistry, University of Alberta, Edmonton, Alberta T6G 2G2, Canada
    • ,
  • Ron Cavell

      Affiliations

    • Department of Chemistry, University of Alberta, Edmonton, Alberta T6G 2G2, Canada
    • ,
  • John R. Mercer

      Affiliations

    • Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta T6G 2N8, Canada
    • Faculty of Medicine, Oncologic Imaging, Cross Cancer Institute, Edmonton, Alberta T6G 1Z2, Canada
    • Corresponding Author InformationCorresponding author. Faculty of Medicine, Oncologic Imaging, Cross Cancer Institute, Edmonton, Alberta, Canada T6G 1Z2. Tel.: +1 780 989 4312; fax: +1 780 432 8483.

Received 12 January 2006; received in revised form 14 June 2006; accepted 15 June 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0969-8051(06)00105-3

doi:10.1016/j.nucmedbio.2006.06.004

Nuclear Medicine and Biology
Volume 33, Issue 6 , Pages 715-722, August 2006

Article Tools

* Image Usage & Resolution